상단으로 가기
컨텐츠 바로가기

GLOBAL MARKET
Hana Pharm is moving forward to a global market

HOME Research & Development Global Business

Global Business

We are expanding global presence
and strengthening partnerships
with the global companies.

"We have successfully obtained GMP certifications from major global regulatory authorities, including Japan's PMDA and European agencies. Leveraging these credentials, we are actively conducting Finished Pharmaceutical Product (FPP) CMO business tailored for the Japanese and European markets.

Furthermore, through close strategic partnerships with global players, we continue to expand our export footprint for finished products across Southeast Asia, Central Asia, and the MENA (Middle East & North Africa) region. In addition, we ensure a stable and reliable supply of high-quality Active Pharmaceutical Ingredients (APIs) to the Japanese market."

Inquiry on global business
  • We have established a solid position in the overseas market with our well-balanced and rich pipeline as narcotics and anesthetics specialty company in S. Korea.

    • Sevofran Liquid for Inhalation (Sevoflurane)
    • Ifran Liquid for Inhalation (Isoflurane)
    • Anepol Injection (Propofol)
    • Vascam Injection (Midazolam)
    • Dexmedine Injection (Dexmedetomidine HCl)
    • Hana Bupivacaine HCI Injection 0.5% (Bupivacaine HCl)
    • Hana Bupivacaine HCI Heavy Injection 0.5%
         (Bupivacaine HCl, Dextrose)
    • Hana Fentanyl Citrate Injection (Fentanyl Citrate)
    • Remiva Injection (Remifentanil)
    • Ocodone Injection (Oxycodone HCl Hydrate)
  • Based on continuous research and industry-leading quality management, our high-quality synthetic APIs are stably supplied to major pharmaceutical companies both domestically and internationally, including those in Japan.

    • Granisetron HCl
    • Ramosetron HCl
    • Flecainide acetate
    • Bepotastine besilate
    • Diacerein
    • Propiverine HCl
    • Meloxicam
    • Ondansetron HCl